![Cover Image for [PM] Nucleate New York: The Forum](https://images.lumacdn.com/cdn-cgi/image/format=auto,fit=cover,dpr=2,background=white,quality=75,width=400,height=400/event-covers/j2/1a1efc68-a0b0-4e10-9b0a-ce051022c6f9.png)
[PM] Nucleate New York: The Forum
Nucleate New York Presents The Forum 2025 (formerly known as Demo Day), our 4th Annual Ecosystem Celebration on May 16th, 2025.
This flagship event brings together innovators, builders, and thinkers from across the ecosystem for a day of insight, connection, and momentum. Whether you're launching your first company, fundraising, advising startups, investing in breakthrough science, translating research at the bench, or building the infrastructure and communities that make innovation possible, the Forum is where biotech’s future takes shape.
🎙️ FEATURED SPEAKERS:
Andrea Califano, PhD | President, Chan Zuckerberg Biohub New York
Elma Hawkins, PhD, MBA | Executive in Residence, Columbia Technology Ventures and Executive Chairwoman, Thylacine Biotherapeutics
Stacy Blain, PhD | CEO and Founder, Concarlo Therapeutics
📅 AGENDA
[1:30 - 2:00 pm] Registration Opens
[2:00 - 2:15 pm] State of Nucleate Presentation
Chichi Chang, co-Managing Director, Nucleate New York
[2:15 - 2:30 pm] Activator Stories
NYCEDC Company Award Pitch
Nucleate New York Award Pitch
[2:30 - 3:20 pm] Featured Fireside Chat
Dr. Andrea Califano, President, Chan Zuckerberg Biohub New York
Clyde and Helen Wu Professor of Chemical and Systems Biology at Columbia University
Dr. Califano is an internationally recognized pioneer in the reverse engineering of gene regulatory networks and in their analysis to systematically and efficiently identify key tumor checkpoint modules, whose aberrant activity is necessary for tumor viability. Dr. Califano is very active nationally, serving on numerous editorial and scientific advisory boards, including the Board of Scientific Advisors of the National Cancer Institute, St. Jude Children’s Hospital, The MIT Koch Cancer Center, Cancer Genetics Inc., and Thermo Fisher Scientific Inc., among others. He is a member of the National Academy of Medicine, a fellow of the AACR, ISCB, AAAS, and IEEE, recipient of the 2015 and 2022 NCI Outstanding Investigator Award (R35), the 2019 Ruth Leff prize in pancreatic cancer research, and the 2023 Alfred G. Knudson prize in Cancer Genetics. He is also the Co-founder and Chief Scientific Advisor of DarwinHealth Inc.
[3:20 - 3:35 pm] Activator Stories
MilliporeSigma Company Award Pitch
Anylyam Company Award Pitch
[3:35 - 4:15 pm] Break
[4:15 - 5:00 pm] Panel Discussion
Designing the Future of Biotech: What Will Matter in 2035?
[5:00 - 6:30 pm] Open Reception
🎙️ WHY ATTEND!
Insightful Sessions: Hear from top industry leaders about what’s next in the rapidly evolving world of biotech – where discovery meets design. What will research, entrepreneurship and collaboration look like in a future shaped by AI labs, robotic research, and gym-distributed longevity products?
Discover Cutting-Edge Tech: Meet Nucleate’s emerging founders as they showcase state-of-the-art innovations. Dive into one-on-one conversations and explore the breakthroughs shaping the future of biotech in NYC and beyond.
Build Deep Connections: Nucleate New York brings together founders, researchers, investors, and ecosystem builders to strengthen the greater biotech network. If you’re building, fundraising, operating, researching, or investing in biotech or eco, come share your ideas and thesis with the community!
Exclusive Networking Opportunities: Engage directly with founders, VCs, industry leaders, and government representatives
Don't miss this opportunity to connect with the brightest minds in biotech and help shape the future of innovation in New York City.
Please note: Due to space limitations and high interest, the AM and PM sessions require separate registrations. If you would like to attend the AM session, please register using the following link: Nucleate New York: The Forum, AM.
The Forum is powered by Fenwick & West LLP, New York City Economic Development Corporation (NYCEDC), and Pliancy,
Nucleate New York's Activator program is supported by New York City Economic Development Corporation (NYCEDC), Pliancy, and Gunderson Dettmer.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma
Philanthropic Support: Lyda Hill Philanthropies
Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout
In-Kind Support: AcademicLabs, Lens.org, SynBioBeta
About the Event Host
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.